Key facts
- SPHERA FUNDS MANAGEMENT LTD. filed SCHEDULE 13G/A for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK).
- Disclosed ownership: 7.5%.
- Date of event: 10 Apr 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 7.5% | 2,571,426 | 0 | 2,571,426 | /s/ Adi Hanetz | Adi Hanetz / General Counsel | |
| Sphera Global Healthcare GP Ltd. | 7.5% | 2,571,426 | 0 | 2,571,426 | /s/ Adi Hanetz | Adi Hanetz / General Counsel | |
| Sphera Global Healthcare Management LP. | 7.5% | 2,571,426 | 0 | 2,571,426 | /s/ Adi Hanetz | Sphera Global Healthcare Management LP. |
CIK / CUSIP context first